Quinine sulphate @ - Anti-malarials- (FDC- List ) - (Aug 2006)
Drug Name:Quinine sulphate @ - Anti-malarials- (FDC- List ) - (Aug 2006)
List Of Brands:
Indication Type Description:
Drug Interaction
Indication
Adverse Reaction
Contra-Indications
Dosages/ Overdosage Etc
Other Information
Patient Information
Pharmacology/ Pharmacokinetics
Interaction with Food
Pregnancy and lactation
Drug Interaction:
Drug interactions -summary
Quinine sulphate +
Aluminium contng antacids-
delay or decrease absorption of concurrent quinine.
Anticoagulants oral -
quinine depress the hepatic enzyme system that synthesis
Vitamin K dependent clotting factors and enhance the action of
warfarin and other oral anticoagulants
Cimetidine
reduce quinine oral clearance and increase its elimination half-life.
Digoxin
serum concentrations increased by concurrent quinine.
Mefloquine
do not use concurrently with quinine.
if required to be used delay meloquine admin. by at least 12 hours
after last dose of quinine. Risk of convulsions increased by coadmin.
Neuromuscular blocking agents-
blockade of these agents is potentiated by quinine, and result
in respiratory difficulties
Urinary alkalinizers , acetazolamide , Sod bicarb
administered concurrently with quinine increase quinine blood levels.
Drug/Lab Test Interaction: Elevated values for 17 ketogenic steroids may occur with Zimmerman method.
Indication:
Malaria
Adverse Reaction:
Cichonism may occur in therapeutic doses. Acute hemolysis, hemolytic anemia,
Thrombocytopenic purpura Agranulocytosis, hyperprothrombinemia.
Visual disturbances, including disturbed colour vision and perception,
Photophobia,blurred vision with scotomata Night blindness, amyblyopia,
Diplopia,diminished visual fields. Tinnitus, deafness, Vertigo, headache, fever,
Apprehension, reslessness, Confusion, syncope.
Cutaneous rashes, flushing, Sweating, facial oedema.
Contra-Indications:
Hypersensitivity to quinine,glucose -6-phosphate dehydrogenase(G6PD) deficiency, optic neuritis, history of back water fever and thrombocytopenic purpura (associated with previous quinine ingestion), pregnancy.
Special precautions:
Discontinue quinine if there is any evidence of hypersensitivity. Continuous flushing, pruritus, skin rashes, fever, gastric distress, dyspnea, ringing in the ears and visual impairment may occur, particularly only with small doses of quinine.
Extreme flushing of the skin followed by intense,generalised pruritus is most common.
Pregnancy- Quinine has an oxytocic action that appears to occur only with doses that are higher than those recommended It also crosses the placenta. Congenital malformation have occured primarily in large doses (upto 30g) for attempted abortion.
Lactation- Quinine is excreted in breast milk in small amounts. Although no adverse efects have been reported in the nursing infant, rule out patients at risk for G6PD deficiency before breast feeding.
Dosages/ Overdosage Etc:
Indication
Malaria
Dosage:
Adults- 650mg every 8 hours for 5 to 7 days
Children- 25mg/kg/day in divided doses every 8 hours for 5 to 7 days..
Other Information:
Vestibular Disorders
Drugs causing adverse reactions ( 388 )
1. Aminoglycosides
2. Quinine
3. Mustine
Patient Information:
1.To be taken with meals or after meals.
2. May cause diarrhea, nausea, stomach cramps, or pain and vomiting, ringing of ear. Notify physician
3. Stop the drug if there is an indication of allergy, viz flushing, itching, rash.
. AVOID CONCURRENT USE WITH ERYTHROMYCIN
Pharmacology/ Pharmacokinetics:
Interaction with Food:
Not significant
Pregnancy and lactation:
Pregnancy-
Quinine has an oxytocic action that appears to occur only with doses that are higher than those recommended It also crosses the placenta. Congenital malformation have occured primarily in large doses (upto 30g) for attempted abortion.
Lactation
Quinine is excreted in breast milk in small amounts. Although no adverse efects have been reported in the nursing infant, rule out patients at risk for G6PD deficiency before breast feeding.